# Summit Therapeutics Inc.: Form DEF 14A, filed Oct 19, 2026

- Company: [Summit Therapeutics Inc.](/companies/smmt.md) (CIK 1599298)
- Form: DEF 14A
- Filed: 2026-10-19
- Accepted by EDGAR: Oct 19, 2026, 07:01 ET
- Period: 2026-11-04
- Accession: 0001193125-26-424642
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1599298/000119312526424642/d126889ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1599298/000119312526424642/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1599298/000119312526424642/d126889ddef14a.htm

Filed Oct 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-424642. Last ingested by Listed: Nov 4, 2026, 19:36 ET. No prices; not investment advice.
